Optical coherence tomography in bioabsorbable stents: Mechanism of vascular response and guidance of stent implantation

Minerva Cardioangiologica

Volumn 62, Issue 1, 2014, Pages 71-82

  Mattesini, A ^a,b   Pighi, M ^a   Konstantinidis, N ^a   Ghione, M ^a   Kilic, D ^a   Foin, N ^c   Dall'Ara, G ^a   Secco, G G ^d   Valente, S ^b   Di Mario, C ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d DEPARTMENT OF CARDIOLOGY   (Singapore)

Author keywords

Optical coherence Stents Coronary artery disease; Tomography

Indexed keywords

EVEROLIMUS; POLYLACTIC ACID; LACTIC ACID; POLYMER;

BALLOON DILATATION; BIOABSORBABLE STENT; BIODEGRADABLE VASCULAR SCAFFOLD; BIORESORBABLE SCAFFOLD; BLOOD VESSEL REACTIVITY; COMPARATIVE STUDY; FOLLOW UP; HEALING; HUMAN; HYPERPLASIA; IN VIVO STUDY; METAL IMPLANTATION; METAL STENT; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVIEW; STENT; THROMBUS; TISSUE INJURY; VASCULAR RESTORATION THERAPY; VASCULAR SURGERY; BIODEGRADABLE IMPLANT; CHEMISTRY; CORONARY ARTERY DISEASE; PROCEDURES; TIME FACTOR;

ABSORBABLE IMPLANTS; CORONARY ARTERY DISEASE; HUMANS; LACTIC ACID; PERCUTANEOUS CORONARY INTERVENTION; POLYMERS; STENTS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84900355142     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Ormiston JA, Serruys PW. Bioabsorbable coronary stents. Circ Cardiovasc Interv 2009;2:255-60.
2. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 2008;371:899-907. (Pubitemid 351384734)
3. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009;373:897-910.
4. Viceconte N, Chan PH, Barrero EA, Ghilencea L, Lindsay A, Foin N et al. Frequency domain optical coherence tomography for guidance of coronary stenting. Int J Cardiol 2013;166:722-8.
5. Farooq V, Serruys PW, Heo JH, Gogas BD, Onuma Y, Perkins LE et al. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice. JACC Cardiovasc Interv 2013;6:523-32.
6. Onuma Y, Serruys PW, Perkins LE, Okamura T, Gonzalo N, Garcia-Garcia HM et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation 2010;122:2288-300.
7. Okamura T, Garg S, Gutierrez-Chico JL, Shin ES, Onuma Y, Garcia-Garcia HM et al. In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial. Eurointervention 2010;5:932-8.
8. Gomez-Lara J, Brugaletta S, Diletti R, Garg S, Onuma Y, Gogas BD et al. A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds. Eur Heart J 2011;32:294-304.
9. Maehara A, Mintz GS, Weissman NJ. Advances in intravascular imaging. Circ Cardiovasc Interv 2009;2:482-90.
10. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435-41. (Pubitemid 46717966)
11. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 2012;59:1058-72.
12. Gutierrez-Chico JL, Gijsen F, Regar E, Wentzel J, de Bruyne B, Thuesen L et al. Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process. JACC Cardiovasc Interv 2012;5:428-35.
13. Foin N, Ghione M, Mattesini A, Dall'ara G, Davies JE, Di Mario C. Early coverage of Bioabsorbable Scaffold after STEMI analysed by 2D and 3D optical coherence tomography. Cardiovasc Revasc Med 2013;14:363-4.
14. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-95. (Pubitemid 24256751)
15. Serruys PW, Garcia-Garcia HM, Onuma Y. From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J 2012;33:16-25b.
16. Awolesi MA, Sessa WC, Sumpio BE. Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J Clin Invest 1995;96:1449-54.
17. Hamilos M, Sarma J, Ostojic M, Cuisset T, Sarno G, Melikian N et al. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circ Cardiovasc Interv 2008;1:193-200.
18. Ormiston JA, Stewart FM, Roche AH, Webber BJ, Whitlock RM, Webster MW. Late regression of the dilated site after coronary angioplasty: a 5-year quantitative angiographic study. Circulation 1997;96:468-74. (Pubitemid 27329422)
19. Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 2005;111:3435-42. (Pubitemid 40923397)
20. Sarno G, Onuma Y, Garcia Garcia HM, Garg S, Regar E, Thuesen L et al. IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus-eluting device during the bioabsorption process. Catheter Cardiovasc Interv 2010;75:914-8.
21. Onuma Y, Serruys PW. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 2011;123:779-97.
22. Secco GG, Foin N, Viceconte N, Borgia F, De Luca G, Di Mario C. Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons. Eurointervention 2011;7:828-34.
23. Diaz JF, Gomez-Menchero A, Cardenal R, Sanchez-Gonzalez C, Sanghvi A. Extremely high-pressure dilation with a new noncompliant balloon. Tex Heart Inst J 2012;39:635-8.
24. Foin N, Ghione M, Mattesini A, Davies JE, Di Mario C. Bioabsorbable scaffold optimization in provisional stenting: insight from optical coherence tomography. Eur Heart J Cardiovasc Imaging 2013;14:1149.
25. Di Mario C, Iakovou I, van der Giessen WJ, Foin N, Adrianssens T, Tyczynski P et al. Optical coherence tomography for guidance in bifurcation lesion treatment. Eurointervention 2010;6(Suppl):J99-J106.
26. Foin N, Mattesini A, Ghione M, Dall'ara G, Sen S, Nijjer S et al. Tools & Techniques Clinical: Optimising stenting strategy in bifurcation lesions with insights from in vitro bifurcation models. Eurointervention 2013;9:885-7.
27. Di Mario C, Foin N, Colombo A. Kissing vanishing stents: are we trading ephemeral benefit for permanent damage? Eurointervention 2013;9:777-9.
28. Foin N, Alegria E, Sen S, Petraco R, Nijjer S, Di Mario C et al. Importance of knowing stent design threshold diameters and post-dilatation capacities to optimise stent selection and prevent stent overexpansion/ incomplete apposition during PCI. Int J Cardiol 2013;166:755-8.
29. Farooq V, Gomez-Lara J, Brugaletta S, Gogas BD, Garcia-Garcia HM, Onuma Y et al. Proximal and distal maximal luminal diameters as a guide to appropriate deployment of the ABSORB everolimus-eluting bioresorbable vascular scaffold: a sub-study of the ABSORB Cohort B and the on-going ABSORB EXTEND Single Arm Study. Catheter Cardiovasc Interv 2012;79:880-8.
30. Latib A, Costopoulos C, Naganuma T, Colombo A. Which patients could benefit the most from bioresorbable vascular scaffold implant: from clinical trials to clinical practice. Minerva Cardioangiol 2013;61:255-62.
31. Onuma Y, Serruys PW, Gomez J, de Bruyne B, Dudek D, Thuesen L et al. Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent. Catheter Cardiovasc Interv 2011;78:3-12.
32. Prati F, Guagliumi G, Mintz GS, Costa M, Regar E, Akasaka T et al. Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. Eur Heart J 2012;33:2513-20.
33. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2005;45:995-8. (Pubitemid 40432428)
34. Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L et al. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxeleluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. JACC Cardiovasc Interv 2009;2:1269-75.
35. Hoffmann R, Morice MC, Moses JW, Fitzgerald PJ, Mauri L, Breithardt G et al. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials. Heart 2008;94:322-8. (Pubitemid 351303424)
36. Steinberg DH, Mintz GS, Mandinov L, Yu A, Ellis SG, Grube E et al. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC Cardiovasc Interv 2010;3:486-94.
37. Gori T, Schultz E, Hink U, Wenzel P, Post F, Jabs A et al. Early outcome after implantation of ABSORB bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes. Eurointervention 2014; 9:1036-41.
38. Widimsky PLL, Budesinsky T, Tousek P editors. Bioresorbable Vascular Scaffolds in Acute STEMI (PRAGUE-19 study). Paris: EuroPCR 2013.
39. Jaguszewski M, Wyss C, Alibegovic J, Luscher TF, Templin C. Acute thrombosis of bioabsorbable scaffold in a patient with acute coronary syndrome. Eur Heart J 2013;34:2046.